Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

China flag China · Delayed Price · Currency is CNY
7.91
+0.61 (8.36%)
Jul 3, 2026, 3:00 PM CST
Market Cap4.37B +44.1%
Revenue (ttm)1.78B +1.1%
Net Income61.07M +98.3%
EPS0.11 +97.9%
Shares Out 552.92M
PE Ratio71.85
Forward PEn/a
Dividend0.01 (0.18%)
Ex-Dividend DateJan 9, 2026
Volume44,513,751
Open7.35
Previous Close7.30
Day's Range7.30 - 8.03
52-Week Range5.66 - 9.44
Beta0.68
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:600222

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the manufacture and sale of pharmaceutical preparations and Chinese herbal medicine slices in China. The company offers Shuanghuanglian oral liquid series, Shuangjinlian mixture, children's heat-clearing and cough-relieving oral liquid series, pediatric antipyretic oral liquid, Jiaweishanxiang Zhengqi compound preparation, honeysuckle dew, danshen oral liquid, Shengmai Yin, pediatric compound chicken gizzard chewable tablets, Chewable tablets, huperzine A tablets, Wuzi Yanzong oral liquid, co... [Read more]

Sector Healthcare
Founded 1998
Employees 2,084
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600222
Full Company Profile

Financial Performance

In 2025, SHA:600222's revenue was 1.76 billion, a decrease of -9.46% compared to the previous year's 1.94 billion. Earnings were 60.00 million, an increase of 18.74%.

Financial Statements